GENETIC POLYMORPHISMS OF THE GLUTATHIONE S-TRANSFERASE AND CYP1A1 GENES IN KOREAN ORAL SQUAMOUS CELL CARCINOMA

한국인 구강 편평세포암에서 Glutathione S-transferase와 CYP1A1 유전자의 다형성

  • Cha, In-Ho (Dept. of Oral & Maxillofacial Surgery, Dental College, Yonsei University) ;
  • Kwon, Jong-Jin (Dept. of Dentistry, Medical Colllege, Korea University) ;
  • Park, Kwang-Kyun (Dept. of Oral Biology, Dental College, Yonsei University)
  • 차인호 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 권종진 (고려대학교 의과대학 치과학교실) ;
  • 박광균 (연세대학교 치과대학 구강생물학교실)
  • Published : 2002.10.30

Abstract

Many chemical compopunds are converted into reactive electrophilic metabolites by the oxidative(Phase I) enzymes, which are mainly cytochrome P-450 enzyme(CYPs). Phase II conjugating enzymes, such as glutathione S-transferase(GST), usually act as inactivation of enzymes. Genetic polymorphisms have been found to be associated with increased susceptibility to cancer of the lung, bladder, breast and colorectal. Many of the polymorphic genes of carcinogen metabolism show considerably different type of cancer among different ethnic groups as well as individuals within the same group. The aim of this study is (1) to establish the frequencies of genetic polymorphisms of GSTM1 and CYP1A1 in Korean oral squamous cell carcinoma(SCC), (2) to associate oral SCC with the risk of these genetic polymorphisms. The genetic polymorphisms of the GSTM1 and the CYP1A1 genes among 50 Korean oral SCC were analyzed using polymerase chain reaction(PCR). The results suggest that the homozygote and the mutant type of CYP1A1 MspI polymorphisms may be associated with genetic susceptibility to oral SCC in Korean. A combination of the GSTM1 null type with the homozygote(m1/m1), and the mutant(m2/m2) type of CYP1A1 MspI polymorphisms showed a relatively high risk of oral SCC in Korean. In the smoking group, the GSTM1 wild genotype may be the high risk factor of oral SCC in Korean. These data coincide with the hypothesis which states that different susceptibility to cancer of genetic polymorphisms exist among different ethnic group and different types of human cancer.

Keywords

References

  1. IARC. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon, IARC Scientific Publications, Vol.148, 1999
  2. Perera, F.P., Weistein, I.B. : Molecular epidemiology: recent advances and future directions. Carcinogenesis, 21:517-524, 2000
  3. Wolf, C.R., Smith, C.A.D., Gough, A.C., Moss, J.E., Vallis, K.A., Howard, G., Carey, F.J., Mills, K., McNee, W., Carmichael, J., Spurr, N.K. : Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis, 13:1035-1038, 1992
  4. Hirvonen, Ari. : Genetic factors in individual responses to environmental exposures. J. Occupational & Environmental Med., 37:37-43, 1995
  5. Kawajiri, K., Fujii-Kuriyama, Y. : P450 and Human Cancer. Jpn. J. Cancer Res., 82: 1325-1335, 1991
  6. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hiroven, A., Pelkonen, O. : Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility- a review. Gene, 159:113-121, 1995
  7. Worrall, S.F., Corrigan, M., High, A., Starr, D., Matthias, C., Wolf, C.R., Jones, P.W., Hand, P., Gilford, J., Farrell, W.E., Hoban, P., Fryer, A.A, Strange, R.C., : Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450CYP2D6. Phamacogenetics, 8:433-439, 1998
  8. Tanimoto, K., Hayashi, S-I., Yoshiga, K., Ichigawa, T. : Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol., 35:191-6, 1999
  9. Nomura, T., Noma, H., Shibahara, T., Yokohama, A., Muramatusu, T., Ohmori, T. : Aldehyde dehydrogenase 2 and glutathione S-transferase M1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers.Oral Oncol.. 36: 42-46, 2000
  10. Park, J.Y., Muscat, J.E., Ren, P., Schantz, S.P., Harwick, R.D., Stern, J.C., Pike, V., Richie, J.P.Jr., Lazarus, P. : CYP1A1 and GSTM polymorphisms and oral cancer risk. Cancer Epidemiol. Biomark. Prev., 6:791-797, 1997
  11. Hong, Y-S., Chang, J-H., Kwon, O-J., Ham, Y-A., Choi, J-H. : Polymorphism of the CYP1A1 and glutathione-S-trransferase genes in Korean lung cancer patients. Experimental and Molecular Medicine, 30:192-198, 1998
  12. 박수경, 강대희, 유근영, 이승준, 김영철, 강한성, 서준석, 안세현, 노동영, 최국진 : 한국인 유방암에서 GSTM1, T1 유전자 다형성의 역할에 관한 환자-대조군 연구(preliminary report). J. Korean Cancer Assoc., 31:653-662, 1999
  13. Hayashi, S-I., Watanabe, J., Nakachi, K., Kawajiri, K. : PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res., 19(17):4797, 1991
  14. Deakin, M., Elder, J., Hendrickse, C., Peckham, D., Baldwin, D., Pantin, C., Wild, N., Leopard, P., Bell, D.A., Jones, P., Duncan, H., Brannigan, K., Alldersea, J., Fryer, A., Strange, R.C. : Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17:881-884, 1996
  15. Hayashi, S-I., Watanabe, J., Nakachi, K., Kawajiri, K. : Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J.Biochem., 110:407-411, 1991
  16. Wolf, C.R., Smith, C.A.D., Forman, D. : Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibility. Br. Med. Bull., 50:718-731, 1994
  17. Hayashi, S.I., Watanabe, J., Kawajiri, K. : High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class Glutathione Stransferase genes. Jpn. J. Cancer Res., 83:866-870, 1992
  18. Nimura, Y., Yokoyama, S., Fujimori, M., Aoki, T., Adachi, W., Nasu, T., He, M., Ping, Y.M., Lida, F. : Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer, 80:852-857, 1997
  19. Nakachi, K., Hayashi, S-Ⅰ., Kawajiri, K., Imai, K. : Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinocarcinoma of the lung by grades of differentiation. Carcinogenesis, 16:2209-2213, 1995
  20. Guengerich, F.P. : Metabolism of chemical carcinogens. Carcinogenesis, 21:345-351, 2000
  21. Hiroven, A., Nylund, L., Kociba, P., Husgafvel-Pursiainen, K., Vainio, H. : Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis, 15:813-815, 1994
  22. Annette, L., Loic, L.M. : A Simple Mouthwash Method for Obtaining Genomic DNA in Molecular Epidemiological Studies. Cancer Epidemiol. Biomark. Prev., 7:719-24, 1998